Agena Bioscience® in the News

Recent Press Releases

  • Agena Announces MassARRAY® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

    San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics

  • GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More

    New York, NY (360DX), June 6, 2018 –  For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going where the growth is, and for

  • Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More

    San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical

  • Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union More

    San Diego, CA, November 30, 2017 – Agena Bioscience, a global provider of molecular genetic solutions, today announced it has been selected to participate

  • Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One More

    The collaboration will focus on results interpretation for cancer genomics. San Diego, CA, October 5, 2017– Agena Bioscience, a global provider of molecular

  • Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With the MassARRAY® System More

    San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based